David Kavtaradze MD, Inc.

Cordele, Georgia 31015

3 studies enrolling now · 12 studies all time

What they study most

Covid19, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets — Recruiting now
• Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy — Recruiting now
• HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes — Recruiting now
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications — Completed
• Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400) — Completed